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Abstract
Background: Mutations in the thrombopoietin receptor (MPL) may activate relevant pathways and lead to chronic
myeloproliferative neoplasms (MPNs). The mechanisms of MPL activation remain elusive because of a lack of experimental
structures. Modern computational biology techniques were utilized to explore the mechanisms of MPL protein activation
due to various mutations.
Results: Transmembrane (TM) domain predictions, homology modeling, ab initio protein structure prediction, and
molecular dynamics (MD) simulations were used to build structural dynamic models of wild-type and four clinically
observed mutants of MPL. The simulation results suggest that S505 and W515 are important in keeping the TM domain in
its correct position within the membrane. Mutations at either of these two positions cause movement of the TM domain,
altering the conformation of the nearby intracellular domain in unexpected ways, and may cause the unwanted constitutive
activation of MPL’s kinase partner, JAK2.
Conclusions: Our findings represent the first full-scale molecular dynamics simulations of the wild-type and clinically
observed mutants of the MPL protein, a critical element of the MPL-JAK2-STAT signaling pathway. In contrast to usual
explanations for the activation mechanism that are based on the relative translational movement between rigid domains of
MPL, our results suggest that mutations within the TM region could result in conformational changes including tilt and
rotation (azimuthal) angles along the membrane axis. Such changes may significantly alter the conformation of the adjacent
and intrinsically flexible intracellular domain. Hence, caution should be exercised when interpreting experimental evidence
based on rigid models of cytokine receptors or similar systems.
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Introduction
The myeloproliferative leukemia virus oncogene (MPL)
encodes the thrombopoietin receptor, the major regulator of
megakaryocytopoiesis and platelet formation [1,2]. The MPL
thrombopoietin receptor is a 635–amino acid protein consisting
of two extracellular cytokine receptor domains, a transmem-
brane domain, and an intracellular domain containing two
cytokine receptor box motifs [3]. Upon binding of thrombo-
poietin to the extracellular domain, MPL undergoes significant
conformational changes and homodimerization. This confor-
mational event induces phosphorylation of the intracellular non-
receptor kinase partner of MPL, Janus kinase 2 (JAK2),
initiating the downstream cascades critical in megakaryocyte
and platelet formation [4].
Although JAK2 mutations at amino acid 617 and nearby
positions account for the majority of patients with various forms of
myeloproliferative neoplasms (MPNs), a substantial proportion of
MPN patients lack a JAK2 mutation. Some JAK2 mutation-
negative patients with essential thrombocytopenia and myelofi-
brosis have been reported to have MPL mutations, primarily at
codons 515 and, to a lesser extent, 505 [5,6,7,8,9,10]. A lack of
experimental structures has hindered understanding of the
activation mechanisms of MPL at the atomic level, and the
detailed mechanisms of MPL mutational effects remain elusive.
We have demonstrated that modern computational approaches
can be used to explore the structures and dynamics of biological
molecules, even without experimental structures [11,12]. In fact,
computational approaches sometimes can provide information,
especially insights into dynamical behaviors, which crystal
structures cannot afford. Our previous work revealed possible
origins of the effects of various JAK2 mutations through a series of
molecular dynamics simulations starting with a homology model.
Although not experimentally proven yet, the simulation-derived
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clinical evidence [12].
In this paper we applied computational biology approaches
including, transmembrane domain prediction, homology model-
ing, and ab inito structure prediction, to obtain possible structural
models of MPL. The structural models then served as starting
points for large-scale long-time molecular dynamics simulations.
Possible origins of the effects of MPL mutations at positions 505
and 515 were consolidated. This work represents the first
published attempt to understand pathological effects of mutations
of cytokine receptors at the atomic level.
Methods
The following sections provide detailed descriptions of the
computational approaches employed to identify the possible
transmembrane region of MPL, build the homology model of
the transmembrane region, predict the intracellular region
structure, and merge individual domains to build the final
structure; the setups for molecular dynamics simulations are also
described. The wild-type and four clinically observed mutants
were studied: W515L, W515K, S505N, and S505A.
Transmembrane domain structure
Two transmembrane prediction servers were utilized to predict
the MPL transmembrane domain: HMMTOP [13] predicted that
residues 490 to 513 form the transmembrane domain while
residues 486 to 490 and 514 to 518 are the interface regions;
TMHMM [14] predicted that residues 490 to 512 form the
transmembrane domain. Residues 490 to 512 were thus chosen as
the transmembrane domain and were aligned with a known single-
pass transmembrane protein segment (PDBId:2JPX). The extra-
cellular part of MPL was removed except for residues 481 to 489,
which were retained as a cap of the transmembrane domain. The
alignment and the 2JPX structure were then used as the input
template for the MODELLER program (9v7) [15] to build the
homology model for the transmembrane region. Residues 513 to
517 were also included as the cap in the intracellular region.
Intracellular domain structure
Despite the numerous homologues of MPL in the human
genome, there is no known 3D structure of any homologue
sequence for the MPL intracellular domain. To build the initial
structure of the MPL intracellular domain from residues 517 to
635, we used a well-known ab initio protein prediction technique,
Rosetta algorithm [16], running on the Robetta server [17].
Merged structure
MODELLER was again used to build the merged structure.
The homology model of the transmembrane domain and the
intracellular domain predicted by the Rosetta ab initio method were
used as the template structure for the merged structure. A distance
constraint between L506 and F510 was set to ensure their
experimentally observed hydrogen bond [18].
The merged structure then was inserted into the membrane, a
bilayer of palmitoyloleoyl phosphatidylcholine (POPC) construct-
ed by the VMD package, version 1.8.7 [19]. MPL was placed with
a tilt angle of 0 degrees, and the alpha carbon of residue 501 was
at the center of the membrane bilayer; any membrane molecules
within 3 A ˚ of MPL were removed.
Molecular dynamics (MD) simulation setup
The MPL/membrane complex then was put in a 75 A ˚ by 75 A ˚
by 110 A ˚ TIP3P water box [20] with the longest axis in the
membrane bilayer normal direction. Sodium/chloride ions were
added to reach the physiological concentration of sodium ions
(0.14 M) and overall electric neutrality. The resulting system
contained 59,249 atoms (MPL: 2,577; membrane: 19,028; water:
37,752; Na
+: 17; Cl
2: 17). All preparation steps were done using
the VMD package.
All MD simulations were performed using the NAMD package
(version 2.6) [21] with the CHARMM27 force field [22]. Default
parameters and settings were used except as mentioned below.
Periodic boundary conditions were used along with the isother-
mal-isobaric ensemble (NPT) at 1 atm and 310 K. The smooth
particle mesh Ewald (PME) method [23] was employed with 75,
75, and 120 FFT grid points for the lattice directions x, y, and z,
respectively. A cutoff of 12 A ˚ for non-bonded interactions was
used, with switching van der Waals potential beginning at 10 A ˚
with the SHAKE algorithm [24] applied to bonds involving
hydrogens.
The following procedure was used prior to the data collection
(production) MD simulations. All heavy atoms of MPL were first
restrained at their initial structure positions with a force constant
of 50 kcal/mol/A ˚ 2. Membrane, water, and ion molecules were
first energy-optimized and then underwent the following simulated
annealing: the temperature was first increased from 0 K to 600 K
at constant volume (1 K per ps) and held there for 500 ps, and
then decreased from 600 K to 300 K at 1 K per ps and held at
300 K for 500 ps. The system then was kept at 300 K for 4 ns
with constant pressure at 1 atm. The procedure was then repeated,
resulting in an equilibration simulation of 10 ns for water,
membrane molecules, and ions.
This membrane/water/ion-equilibrated system served as the
starting point for the production simulations. Mutant systems were
created with the VMD package on the basis of the equilibrated
wild-type system; hence, all mutants have the same initial
structure. One or two nearby cations/anions were removed to
reach electric neutrality for mutants involving charge changes,
with an additional 1 ns equilibration of membrane/water/ion.
The restraint force constant then was gradually reduced to 3 kcal/
mole/A ˚ 2 during a 500 ps period, followed by a 2,000-step energy
minimization for all atoms and a 300-ps heating period with the
temperature increased from 0 to 300 K at a rate of 1 K per ps.
In the production runs, a 140-ns MD simulation was performed
for each mutant without any restraining potential applied. The last
100 ns of data were used for data analysis.
Results and Discussion
Since all mutations simulated in this work are located in the
transmembrane region, we first analyzed the impact of these
mutations on the position of the transmembrane domain. The
snapshot of the simulation trajectory of the wild-type MPL at
140 ns is shown in Figure 1, which gives an overview of the
simulation-derived MPL structures. Note that wild-type and
mutant simulations have exactly the same starting structure,
except for the protein side-chains of mutated positions.
Hydrophobic/hydrophilic analysis
Figure 2 shows the radial distribution function (RDF, g(r))
between water molecules and the Cb atoms of residues 491 (upper
panel), 505 (middle panel), and 515 (lower panel). The RDF is the
distribution of the distance between two groups of atoms. The
RDF between water molecules and a protein residue can be
treated as a measure of how deep the residue is buried from the
solvent. Here it is also the measure of how deep a certain residue
buried in the membrane. For residue 491, located near the
MPL S505 W515 Mutational Effects
PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e23396extracellular region (Figure 1), the water RDF has similar shapes
for all mutations. However, the magnitudes of the water RDF
differ among mutants, which implies that the positions of the
whole transmembrane domain were shifted. Residue 505 would be
expected to be deeply buried in the membrane, since it is far from
both the intracellular region and the intracellular region, based on
the sequence. Nevertheless, the wild-type and S505N simulations
both show significant water distribution around residue 505; the
data imply that S505 and N505 both interact with water molecules
from the intracellular region, with N505 having a stronger
interaction with water. In fact both simulations revealed that the
membrane had a small opening from time to time, allowing a few
water molecules to enter the membrane and contact the residue
505 side-chain. Note that it is not possible to observe this type of
interaction in a crystal structure. The polar side-chains of S505
and N505 are clearly the source of the interaction; S505A, which
has a less polar side-chain, exhibits a much smaller water RDF.
The polarity of residue 505 has been experimentally reported to be
critical in the conformational changes of MPL [25]. W515L and
W515K alter the position of the whole transmembrane region
such that residue 505 is can no longer access the intracellular
water molecules.
The water RDF for the residue 515 (Figure 2, lower panel)
shows that W515 is located at the interface between the
intracellular region and the membrane. This finding is consistent
with other studies [26,27] and suggests that tryptophan can serve
as an interface anchor for membrane proteins. In fact, W491 and
W515 could be the anchor points for the transmembrane domain
for the extracellular and intracellular regions, respectively, as they
have similar water RDF results. Nevertheless, W515K and S505N
show larger water distributions than the wild-type MPL,
suggesting that the transmembrane domain moves toward the
intracellular region in both mutants. W515L has an opposite effect
in that the RDF is smaller and the L515 residue is buried more
deeply in the membrane. S505A has an RDF similar to that of the
wild-type MPL, suggesting that this mutation does not have a
significant effect on the position of W515.
MPL transmembrane domain tilt angle relative to cell
membrane
The above analysis of water RDF describes the water
distribution around certain resides. Subsequently, we further
identified the relative position changes of the MPL transmem-
brane domain by examining relevant geometrical variables.
The transmembrane tilt angle, defined in Figure 1, describes the
degree of tilting of the transmembrane domain in cell membrane.
The starting structures of wild-type and all MPL mutants have tilt
angles of 0 degrees. Tilt angles derived from all simulations are
listed in Table 1. The results suggest that, for MPL, the
transmembrane tilt angle is significantly deviated from the starting
structures (0 degrees), consistent with other studies [28,29,30,31].
The RDF distributions in fact suggest that W491 and W515 are
the anchor points on the membrane/water interfaces and may
Figure 1. Snapshot of the simulation trajectory of wild-type
MPL at 140 ns. The gold balls represent the phosphorus atoms of the
membrane bilayer. Three key residues, W491, S505, and W515, are
colored red and indicated by the black arrows. The upper part of the
figures is the extracellular region while the lower part the intracellular
region. The tilt angle h, demonstrated by the red arrows, defines the tilt
of the transmembrane domain relative to the membrane normal.
doi:10.1371/journal.pone.0023396.g001
Figure 2. The radial distribution function (RDF, g(r) ) between
water molecules and the Cb atoms of residues 491 (upper
panel), 505 (middle panel), and 515 (lower panel) of MPL. The
RDF is the distance distribution of two groups of atoms, calculated from
the last 100 ns trajectory for each simulation with a sampling frequency
of 10 ps, (i.e., 10,000 data points for each mutant).
doi:10.1371/journal.pone.0023396.g002
Table 1. MPL Transmembrane Domain Tilt Angles Derived
from Molecular Dynamics Simulations.
Mutant Tilt Angle ﬁ, average (standard deviation)6
WT 27.6 (7.0)
W515L 28.8 (6.4)
W515K 25.1 (7.5)
S505A 21.9 (10.2)
S505N 33.5 (5.8)
ﬁ, angle of tilt of MPL transmembrane domain in relation to the membrane
normal (Figure 1). Average values are calculated from the last 100 ns trajectory
for each simulation, with a sampling frequency of 10 ps (i.e., 10,000 data points
per mutant.
doi:10.1371/journal.pone.0023396.t001
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Figure 1 also shows the positions of W491 and W515 relative to
the membrane.
Although the tilt angles in simulations demonstrated large
deviations (implying mobility of the transmembrane domain inside
the membrane) and it is difficult to draw firm conclusions based
solely on tilt angle statistics, S505A and S505N do appear to
exhibit significant differences in tilt angles (21.9 and 33.5 degrees,
respectively). This finding can be explained by the fact that A505
tends to be buried in the membrane and causes the transmem-
brane domain to be more aligned with the membrane normal
direction, while N505 will have an opposite effect. Similar
observations have been reported in other systems [30].
TM rotation (azimuthal) angle
The tilt angle alone is not enough to describe the relative
position of the transmembrane region, which could also rotate
relative to the intracellular domain. The averages of this rotation
(azimuthal angle) and its distribution derived from simulations are
shown in Figure 3. The starting structures of wild-type and all
MPL mutants have azimuthal angles of 0 degrees. The average
values and distributions of the azimuthal surprisingly vary across
MPL mutants. This may imply that the junction between the
transmembrane and intracellular domains is flexible and can be
locked into different positions when the transmembrane domain
moves along the membrane. This is especially true in the case of
W515K because the charged side chain makes it very hydrophilic,
causing the transmembrane domain to sometimes move toward
the intracellular region. This movement causes the intracellular
domain to undergo almost free rotation as the azimuthal angle
distributes over the entire 360 degrees (Figure 3).
The intracellular domain conformation is highly
dependent on the transmembrane domain position
Whereas there is a consensus that MPL has a is a one-pass
transmembrane membrane domain whose structure is most likely
a single alpha helix, as we have seen in the simulations, there is no
structural evidence for the intracellular domain. Although nuclear
magnetic resonance (NMR) studies have provided experimental
evidence on the hydrogen bonding patterns near the intracellular
domain of MPL [18], the overall folding of the intracellular
domain remains elusive. In this study the Rosetta ab initio protein
structure prediction was used to build the initial structure of the
intracellular domain. Although ab initio protein structure predic-
tion techniques are maturing, we cannot yet reliably assess the
quality of our model structure of the intracellular domain. Hence,
the intracellular domain structures derived from our simulations
(Figure 4) may not be used as reliable structural models. However,
these simulations may be used to derive the impact of
transmembrane domain movement on the intracellular domain
structure.
Snapshots representing the conformational changes of the
intracellular domain due to different mutations are shown in
Figure 4. Three regions contacting the membrane (residues 40–44,
73–79, and 109–114) and the Box1 region (residues 50–53)
responsible for JAK2 binding are highlighted with different colors.
Relative to the wild-type simulation, all mutant simulations
showed significant changes in the positions of these three contact
regions in relation to the membrane. This is intriguing because the
transmembrane and intracellular regions are usually thought of as
individual domains; thus, the strong influence of transmembrane
domain changes on the intracellular region was unexpected. This
finding leads to an interesting issue: can separately crystallized
Figure 3. Effect of MPL mutations on rotation angle along the membrane axis (ie, the azimuthal angle). Left panel: depiction of the
azimuthal angle, defined as the torsion between 4 Ca atoms (red dots) of the MPL intracellular domain. The gold balls represent the phosphorus
atoms of the membrane bilayer. Right panel: distribution of azimuthal angle in all simulations; the average values are indicated next to the mutant
name. The distribution is calculated from the last 100 ns trajectory for each simulation with a sampling frequency of 100 ps (i.e., 1,000 data points for
each mutant).
doi:10.1371/journal.pone.0023396.g003
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the interfaces between the transmembrane and intracellular
domains have a large impact on the latter?
Possible constitutive activation of JAK2 through MPL
S505 and W515 mutations
With the limitations of currently available computational
approaches, the intracellular domain structure reported here is
putative and requires further experimental verification. Neverthe-
less, we examined the possible effects of MPL mutations on the
Box1 loop of the intracellular domain. The Box1 loop is believed
to be the JAK2 binding site [32]. Interestingly, Figure 4 shows that
the Box1 loop (in yellow) is open only in the wild-type MPL. In all
mutants, the Box1 loop is buried or packed with nearby residues.
Although JAK2 was not included in our simulations, the
conformational change of the Box1 loop will likely change the
binding mode between MPL and JAK2. This could explain the
constitutive activation of JAK2 due to S505 and W515 mutations.
Hence, based on the disruption of the azimuthal angle and the
impact on the structure of the intracellular domain, the predicted
order of mutational effects is as follows: W515K . S505A .
W515L . S505N; this predicted order needs to be experimentally
verified.
Possible mechanisms of activation of MPL/JAK2 signaling
pathway
Traditionally the activation of membrane receptors and their
partner kinases is explained by assuming that the individual
domains are more-or-less rigid. Upon binding to the ligand, the
receptor forms a dimer and the relative orientation between
domains of a receptor dimer causes the activation processes
[10,18,33,34,35,36]. The intrinsic tilt angles of transmembrane
domains have seldom been considered, and the azimuthal angles
are usually totally ignored. It has been shown that the
erythropoietin receptor has a juxtamembrane domain containing
an essential and precisely oriented hydrophobic motif, and that
insertion of extra residues may cause different azimuthal angles
between the transmembrane and intracellular domains [37]. This
may suggest that the azimuthal angles between the transmem-
brane and intracellular domains play critical roles in the signaling
activation in similar systems. Our study shows that the MPL
mutants cause significant changes in azimuthal angles and hence
the intracellular domain conformations. Thus, it is possible that
the control of azimuthal angles could be one of the major factors
in signaling activation mechanisms for membrane receptors, as
the azimuthal angle can be changed by rotating the transmem-
brane domain upon ligand binding as proposed in different
systems [38]. The azimuthal angle apparently is determined by
the conformation of the juxtamembrane domain, which has been
recently demonstrated as the center stage of signal activations
[18,39,40,41].
Taken together, the above studies indicate that signal activation
may involve the following events: ligand binding to the receptor
causes rotation of the transmembrane domain and conformational
changes of the juxtamembrane domain, which results in significant
conformational changes of the intracellular domain. The anchor
points of the transmembrane domains are thus critical to holding
the transmembrane domain in the right tilt and azimuthal angles.
Understanding of the detailed conformational changes may
require dynamic descriptions rather than traditional rigid-domain
models.
Figure 4. Snapshots showing the conformational changes of the intracellular (IC) domain due to different mutations. The gold balls
represent the phosphorus atoms of the membrane bilayer. The MPL protein is colored green except for residues 50 to 53 (the Box1 motif, in yellow),
40 to 44 (red), 73 to 79 (blue), and 109 to 114 (white). Snapshots are taken from the simulation trajectories at 140 ns.
doi:10.1371/journal.pone.0023396.g004
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where the transmembrane and intracellular domains are usually
treated as being rigid and the activation of JAK2 is explained by
the relative translational movement between those rigid domains
[10,18,33,34,35] (Figure 5, A-to-B), our results suggest that
mutations within the transmembrane region could result in other
types of conformational changes, including tilt angle and rotation
(azimuthal) angle along the membrane axis (Figure 5, A-to-C).
Such changes may significantly alter the conformation of adjacent
IC domain. Hence we suggest that it may be necessary to consider
these two angles when establishing molecular models for cytokine
signaling events.
Description of the dynamic behavior of membrane
proteins is necessary
An important aspect of this study is that it highlights possible
limitations of crystal structures for studying membrane proteins.
All analyses reported here are based on long-time (140 ns for each
mutant) molecular dynamics simulations that sample over different
local and global conformations of different domains of MPL. The
results cannot be obtained by static models. Although crystallog-
raphy techniques are critically important in structural biology,
crystal structures are averaged structures and cannot provide
dynamic insights. For example, the rotation angle distribution
analysis in the last section gives deep insights into how the
intracellular domain may be influenced by the location of the
transmembrane domain. This type of analysis is not possible with
static crystal structures alone. To deeply understand the activation
process in signaling transduction, other approaches such as NMR
techniques and molecular dynamics simulations are necessary.
Conclusion
We present the first full-scale molecular dynamic simulations on
the wild-type and clinically observed mutants of the MPL
transmembrane protein, a critical element of the related JAK2
signal pathway. Simulation results suggest that S505 and W515
are important in keeping the transmembrane domain in its correct
position. Mutations at these two positions cause movement of the
transmembrane domain, alter the conformation of the nearby
intracellular domain in an unexpected way, and may cause
Figure 5. Schematic representations of the traditional view of activation of the MPL/JAK2 signaling pathway (from A to B), and a
possible alternative view derived from the current work (from A to C). The A-to-B path shows that a ligand (thrombopoietin, TPO) binds to
the extracellular (EC) domain MPL molecule, forming MPL dimers and bringing the transmembrane (TM) and intracellular (IC) domains together. The
A-to-C path suggests that ligand binding changes the tilt (red arrows) and azimuthal (blue arrows) angles of the TM domain, resulting in
conformational changes in the IC domains and the IC-JAK2 binding mode.
doi:10.1371/journal.pone.0023396.g005
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the order of impact of the mutational effects to be in the following
sequence: W515K . S505A . W515L . S505N.
Our results suggest that mutations within the transmembrane
region could cause conformational changes that are seldom
considered, such as the tilt angle change and azimuthal rotational
angle (the angle along the membrane normal) change. Such
changes may significantly alter the conformation of the adjacent
intracellular domain. Hence, extreme caution should be exercised
when interpreting experimental evidence based on rigid models of
cytokine receptors or similar systems.
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